Enerzair Breezhaler [1]
Every 3rd asthma patient on inhaled therapy remains uncontrolled1
|
of patients with asthma remain uncontrolled, despite current treatment with inhaled therapies.*1 |
![]() |
Furthermore, of patients are unable to use their inhaler properly, even with training.**2 |
Persistence of symptoms put patients at a higher risk of asthma attacks.3
Unlock the potential of inhaled asthma care with the ENERZAIR® BREEZHALER® family
With once-daily ENERZAIR® BREEZHALER®,4 your patients can live and breathe every moment.
The ENERZAIR® BREEZHALER® device provides certainty that the full dose has been taken
How to use ENERZAIR® BREEZHALER®
Watch the following video to learn how to use ENERZAIR® BREEZHALER®
Further Information
Click here [2] to learn more about the unmet needs of patients with asthma.
Click here [3] to find out more about the iridium study.
To learn more about Sensor for the ENERZAIR® BREEZHALER® device, click here [4] .
*Baseline data from a retrospective study of 45,804 adult asthma patients in the UK, newly initiated on medium- or high-dose LABA/ICS therapy.1
**96 pharmacies collected data from 570 adult asthma patients in Australia. Of these, 348 patients were taking preventer/combination medication on a regular basis and were included. All patients who demonstrated incorrect technique at Visit 1 were trained to mastery. Of these, data was available for 238 at follow-up visit.2
†The Propeller® Sensor for the BREEZHALER® device (hereinafter referred to as “the Sensor/the Sensor for the BREEZHALER® device”) and the Propeller® mobile app (hereinafter referred to as “the app“) are the property of Propeller Health®.
‡Data derived from studies in COPD patients.7,8
§Compared to Diskus®, HandiHaler®, Respimat® and Turbohaler®.7
¶Compared to Ellipta® and HandiHaler®.8
REFERENCES:
-
Buhl R, et al. Respir Med. 2020;162:105859 [Epub ahead of print].
-
Azzi E, et al. NPJ Prim Care Respir Med. 2017;27:29.
-
GINA Global Strategy for Asthma Management and Prevention. 2019 Update. Available at: https://ginasthma.org/wp-content/ uploads/2019/06/ GINA-2019-main-report-June-2019-wms.pdf [5]. Accessed: February 2020.
-
ENERZAIR® BREEZHALER®. Summary of Product Characteristics. July, 2020 for Atectura.
-
ATECTURA® BREEZHALER®. Summary of Product Characteristics. June, 2020 for Enerzair.
-
Propeller Health®, QR Rationale for EU Classification-2017-B 2019-07-24 Update.
-
Molimard M, et al. Eur Respir J. 2017;49:1601794.
-
Altman P, et al. BMC Pulm Med. 2018;18:100.